Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC

NCT04609540 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab

Sponsor

Shandong Cancer Hospital and Institute